Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Robert Rothermel Insider Profile
4 Followers
Robert Rothermel, Director at DMK Pharmaceuticals, holds 133.50K shares in DMK Pharmaceuticals (Ticker: DMKPQ). Most recently, Robert Rothermel Bought $6,500 shares of DMK Pharmaceuticals on May 28, 2019 for an estimated value of 10.27K.
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-40.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Robert Rothermel's holdings
Insider Roles
Director
Roles that Robert Rothermel holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 02, 2014 - Sep 02, 2015
Return:-26.40%
The most profitable trade made by Robert Rothermel
Robert Rothermel's Trading History
List of latest transactions for each holding click on a transaction to see Robert Rothermel's performance on stock
You May Also Like
Robert Rothermel insider profile FAQ
What is the percentage of profitable transactions made by Robert Rothermel?
The percentage of profitable transactions made by Robert Rothermel is 0%.
What is the average return per transaction made by Robert Rothermel?
The average return per transaction made by Robert Rothermel is -40.20%.
What stocks does Robert Rothermel hold?
Robert Rothermel holds: DMKPQ stocks.
What was Robert Rothermel’s latest transaction?
Robert Rothermel latest transaction was an Informative Buy of $10.27K.
What was Robert Rothermel's most profitable transaction?
Robert Rothermel’s most profitable transaction was an Informative Buy of DMKPQ stock on September 2, 2014. The return on the trade was -26.40%.
What is Robert Rothermel's role in DMK Pharmaceuticals?
Robert Rothermel's role in DMK Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.